While the tech industry prepares for an Executive Order (EO) seeking to limit state regulation of AI, President Trump instead issued an EO ...

YARDLEY, PA — Jubilant Therapeutics Inc. has appointed Daniel J. O’Connor as its new president and chief executive officer, effective December 1, 2025, marking a major leadership shift as the ...

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...

The S&P 500 Healthcare sector (XLV) experienced a rise in average short interest during November, moving from 1.97% to 2.12%.

Included in the 3,000-page bill approved Wednesday by the House is a provision to scrutinize American investments in China ...

Is a new obesity drug making people lose too much weight? Plus catch up on #ASH25 and hear how the country's scientific ...

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

MassBay Community College this week held its Student STEM Expo in Wellesley, enabling those in engineering, math, computer ...

This research led to Balu-Iyer founding the Buffalo-based company Immune Modulatory Therapies LLC in 2019. His UB co-founders ...

Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...